| P50 | author | Lars M. Ittner | Q30347436 |
| | Michael Kassiou | Q48744540 |
| P2093 | author name string | Sook W Chua | |
| P2860 | cites work | Alzheimer's Disease | Q22248111 |
| | Translocator protein (18kDa): new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function | Q24296269 |
| | Cholesterol binding at the cholesterol recognition/ interaction amino acid consensus (CRAC) of the peripheral-type benzodiazepine receptor and inhibition of steroidogenesis by an HIV TAT-CRAC peptide | Q24546891 |
| | An 18-kDa translocator protein (TSPO) polymorphism explains differences in binding affinity of the PET radioligand PBR28 | Q24599479 |
| | The positron emission tomography ligand DAA1106 binds with high affinity to activated microglia in human neurological disorders | Q24641816 |
| | Imaging of peripheral benzodiazepine receptor expression as biomarkers of detrimental versus beneficial glial responses in mouse models of Alzheimer's and other CNS pathologies | Q24642726 |
| | Translocator protein (18 kDa) TSPO: an emerging therapeutic target in neurotrauma | Q24649929 |
| | Neuropathological stageing of Alzheimer-related changes | Q27860862 |
| | Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide | Q28131750 |
| | Inflammation and Alzheimer's disease | Q28138617 |
| | Peripheral benzodiazepine receptors and mitochondrial function | Q28201926 |
| | Translocator protein (18 kD) as target for anxiolytics without benzodiazepine-like side effects | Q28249253 |
| | Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases | Q28269333 |
| | Ligand for translocator protein reverses pathology in a mouse model of Alzheimer's disease | Q28290730 |
| | Translocator protein/peripheral benzodiazepine receptor is not required for steroid hormone biosynthesis | Q28301125 |
| | Peripheral benzodiazepine receptor in cholesterol transport and steroidogenesis | Q28303440 |
| | The mitochondrial permeability transition pore and its role in cell death | Q29614183 |
| | Tau-mediated neurodegeneration in Alzheimer's disease and related disorders | Q29618148 |
| | Mouse TSPO in a lipid environment interacting with a functionalized monolayer | Q30418916 |
| | Translocator protein (18 kDa)/peripheral benzodiazepine receptor specific ligands induce microglia functions consistent with an activated state | Q30649552 |
| | Microglial activation and amyloid deposition in mild cognitive impairment: a PET study | Q33634089 |
| | Convergence of amyloid-beta and tau pathologies on mitochondria in vivo | Q33876147 |
| | Two binding sites for [3H]PBR28 in human brain: implications for TSPO PET imaging of neuroinflammation | Q34171364 |
| | Molecular imaging of microglia/macrophages in the brain | Q34276818 |
| | Mitochondrial benzodiazepine receptors regulate steroid biosynthesis | Q34325284 |
| | Development of ligands for the peripheral benzodiazepine receptor | Q34547615 |
| | Porphyrins are endogenous ligands for the mitochondrial (peripheral-type) benzodiazepine receptor | Q34612661 |
| | Neuroprotective effect of Ro5-4864 following brain injury | Q34826756 |
| | A comparative autoradiography study in post mortem whole hemisphere human brain slices taken from Alzheimer patients and age-matched controls using two radiolabelled DAA1106 analogues with high affinity to the peripheral benzodiazepine receptor (PBR | Q34872399 |
| | Neuroprotective effects of a ligand of translocator protein-18 kDa (Ro5-4864) in experimental diabetic neuropathy. | Q34996330 |
| | Specific benzodiazepine receptors in rat brain characterized by high-affinity (3H)diazepam binding | Q35050152 |
| | Inflammatory processes in Alzheimer's disease | Q35201137 |
| | Astrocytes are important mediators of Aβ-induced neurotoxicity and tau phosphorylation in primary culture. | Q35202286 |
| | Mitochondrial Benzodiazepine Receptors and the Regulation of Steroid Biosynthesis | Q35229114 |
| | In vivo positron emission tomographic imaging of glial responses to amyloid-beta and tau pathologies in mouse models of Alzheimer's disease and related disorders | Q35654128 |
| | Differentiation between two ligands for peripheral benzodiazepine binding sites, [3H]R05-4864 and [3H]PK 11195, by thermodynamic studies | Q51852591 |
| | Evaluation of [¹²³I]-CLINDE as a potent SPECT radiotracer to assess the degree of astroglia activation in cuprizone-induced neuroinflammation. | Q54378366 |
| | A genetic polymorphism for translocator protein 18 kDa affects both in vitro and in vivo radioligand binding in human brain to this putative biomarker of neuroinflammation | Q36684216 |
| | In vivo radioligand binding to translocator protein correlates with severity of Alzheimer's disease. | Q36953874 |
| | Pregnenolone biosynthesis in C6-2B glioma cell mitochondria: regulation by a mitochondrial diazepam binding inhibitor receptor | Q37044498 |
| | Characterization and modeling of the oligomeric state and ligand binding behavior of purified translocator protein 18 kDa from Rhodobacter sphaeroides | Q37130302 |
| | Carbon 11-labeled Pittsburgh Compound B and carbon 11-labeled (R)-PK11195 positron emission tomographic imaging in Alzheimer disease. | Q37153379 |
| | Imaging microglial activation during neuroinflammation and Alzheimer's disease | Q37340359 |
| | PK11195 labels activated microglia in Alzheimer's disease and in vivo in a mouse model using PET. | Q37351230 |
| | The translocator protein (18 kDa): central nervous system disease and drug design | Q37365598 |
| | Amyloid-beta and tau synergistically impair the oxidative phosphorylation system in triple transgenic Alzheimer's disease mice | Q37414108 |
| | Mitochondrial permeability transition pore in Alzheimer's disease: cyclophilin D and amyloid beta | Q37555305 |
| | Translocator protein (18 kDa) (TSPO) as a therapeutic target for neurological and psychiatric disorders | Q37814088 |
| | Amyloid-β and tau--a toxic pas de deux in Alzheimer's disease | Q37824813 |
| | Shedding light on the mitochondrial permeability transition. | Q37850094 |
| | Inflammation in Alzheimer disease-a brief review of the basic science and clinical literature | Q37982377 |
| | Peripheral-type benzodiazepine receptor-mediated action of steroidogenic acute regulatory protein on cholesterol entry into leydig cell mitochondria | Q38335116 |
| | Three-dimensional structure of TspO by electron cryomicroscopy of helical crystals | Q39864742 |
| | Mitochondria are a direct site of A beta accumulation in Alzheimer's disease neurons: implications for free radical generation and oxidative damage in disease progression | Q40301497 |
| | Characterization of peripheral benzodiazepine type sites in a cultured murine BV-2 microglial cell line | Q41249632 |
| | Effects of translocator protein (18 kDa) ligands on microglial activation and neuronal death in the quinolinic-acid-injected rat striatum | Q41964688 |
| | Structural and functional study of reconstituted peripheral benzodiazepine receptor | Q43631731 |
| | In-vivo measurement of activated microglia in dementia | Q43713539 |
| | Etifoxine analgesia in experimental monoarthritis: a combined action that protects spinal inhibition and limits central inflammatory processes. | Q43869315 |
| | In vivo and in vitro peripheral-type benzodiazepine receptor polymerization: functional significance in drug ligand and cholesterol binding. | Q44402442 |
| | Assessment of neuroinflammation and microglial activation in Alzheimer's disease with radiolabelled PK11195 and single photon emission computed tomography. A pilot study | Q44490089 |
| | Age and disease related changes in the translocator protein (TSPO) system in the human brain: positron emission tomography measurements with [11C]vinpocetine | Q44786130 |
| | Cell surface localization of the peripheral-type benzodiazepine receptor (PBR) in adrenal cortex | Q44845409 |
| | Peripheral benzodiazepine receptor ligand PK11195 reduces microglial activation and neuronal death in quinolinic acid-injected rat striatum | Q45296984 |
| | Differential effect of detergents on [3H]Ro 5-4864 and [3H]PK 11195 binding to peripheral-type benzodiazepine-binding sites | Q46227832 |
| | Microglia, amyloid, and cognition in Alzheimer's disease: An [11C](R)PK11195-PET and [11C]PIB-PET study | Q46373170 |
| | Binding of [3H]Ro 5-4864 and [3H]PK 11195 to cerebral cortex and peripheral tissues of various species: species differences and heterogeneity in peripheral benzodiazepine binding sites | Q46596862 |
| | Synthesis and in vivo evaluation of a novel peripheral benzodiazepine receptor PET radioligand | Q46614777 |
| | Secondary and tertiary structures of the transmembrane domains of the translocator protein TSPO determined by NMR. Stabilization of the TSPO tertiary fold upon ligand binding | Q46639005 |
| | Adult mouse astrocytes degrade amyloid-beta in vitro and in situ | Q46779933 |
| | Dihydropyridine and peripheral type benzodiazepine binding sites: subcellular distribution and molecular size determination | Q47216704 |
| | In situ molecular weight determination of brain and peripheral benzodiazepine binding sites | Q47274987 |
| | Proteomic and functional analyses reveal a mitochondrial dysfunction in P301L tau transgenic mice | Q47814284 |
| | In vivo imaging of the 18-kDa translocator protein (TSPO) with [18F]FEDAA1106 and PET does not show increased binding in Alzheimer's disease patients | Q48151150 |
| | Reactive astrocytes overexpress TSPO and are detected by TSPO positron emission tomography imaging. | Q48415784 |
| | Microglial activation in Alzheimer's disease: an (R)-[¹¹C]PK11195 positron emission tomography study | Q48426445 |
| | Astrocytes regulate microglial phagocytosis of senile plaque cores of Alzheimer's disease | Q48512773 |
| | Peripheral-type benzodiazepine receptors in endocrine organs: autoradiographic localization in rat pituitary, adrenal, and testis | Q48532076 |
| | Peripheral benzodiazepine binding sites in Alzheimer's disease frontal and temporal cortex | Q48737055 |
| P433 | issue | 4 | |
| P921 | main subject | Alzheimer's disease | Q11081 |
| P304 | page(s) | 439-448 | |
| P577 | publication date | 2014-04-01 | |
| P1433 | published in | Expert Review of Neurotherapeutics: a key contribution to decision making in the treatment of neurologic and neuropsychiatric disorders | Q15760319 |
| P1476 | title | The translocator protein as a drug target in Alzheimer's disease | |
| P478 | volume | 14 | |